Other characteristics of the Zinc Propanoate can be summarised as followings: (1)ACD/LogP: ; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH ): -; (4)ACD/LogD (pH ): -; (5)ACD/BCF (pH ): 1; (6)ACD/BCF (pH ): 1; (7)ACD/KOC (pH ): ; (8)ACD/KOC (pH ): 1; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 1; (12)Polar Surface Area: Å 2 ; (13)Flash Point: °C; (14)Enthalpy of Vaporization: kJ/mol; (15)Boiling Point: °C at 760 mmHg; (16)Vapour Pressure: mmHg at 25°C.
There are no available data on the presence of fluticasone propionate in human milk, the effects on the breastfed child, or the effects on milk production. Other corticosteroids have been detected in human milk. However, fluticasone propionate concentrations in plasma after inhaled therapeutic doses are low and therefore concentrations in human breast milk are likely to be correspondingly low [see Clinical Pharmacology ()] . The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Flovent HFA and any potential adverse effects on the breastfed child from Flovent HFA or from the underlying maternal condition.